Reduction of diastolic blood pressure: Should hypertension guidelines include a lower threshold target?

被引:1
作者
Steven Tringali [1 ]
Jian Huang [1 ,2 ]
机构
[1] Department of Medicine, Uni-versity of California San Francisco-Fresno Medical Education Program
[2] Department of Medicine, Veterans Administration Central California Health Care System
关键词
Blood pressure; Guideline; J-curve; Hypertension; Diastolic pressure;
D O I
暂无
中图分类号
R544.1 [高血压];
学科分类号
1002 ; 100201 ;
摘要
Reduction of diastolic blood pressure to less than 60-80 mm Hg does not improve mortality and may lead to adversecardiovascular events in high risk patient populations. Despite a growing body of evidence supporting the J-curve phenomenon, no major society guidelines on hypertension include a lower threshold target for diastolic blood pressure. Many major society guidelines for hypertension have been updated in the last 5 years. Some guidelines include goals specific to age and co-morbid conditions. The Sixth Joint Task Force of the European Society of Cardiology and the Canadian Hypertension Education Program are the only guidelines to date that have recommended a lower threshold target, with the Canadian guidelines recommending a caution against diastolic blood pressure less than or equal to 60 mm Hg in patients with coronary artery disease. While systolic blood pressure has been proven to be the overriding risk factor in hypertensive patients over the age of 50 years, diastolic blood pressure is an important predictor of mortality in younger adults. Post hoc data analysis of previous clinical trials regarding safe lower diastolic blood pressure threshold remains inconsistent. Randomized clinical trials designed to determine the appropriate diastolic blood pressure targets among different age groups and populations with different comorbidities are warranted. Hypertension guideline goals should be based on an individual’s age, level of risk, and certain co-morbid conditions, especially coronary artery disease, stroke, chronic kidney disease, and diabetes.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 23 条
[1]  
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis[J] . Xinfang Xie,Emily Atkins,Jicheng Lv,Alexander Bennett,Bruce Neal,Toshiharu Ninomiya,Mark Woodward,Stephen MacMahon,Fiona Turnbull,Graham S Hillis,John Chalmers,Jonathan Mant,Abdul Salam,Kazem Rahimi,Vlado Perkovic,Anthony Rodgers.The Lancet . 2016 (1001)
[2]  
Hypertension Guidelines: Is It Time to Reappraise Blood Pressure Thresholds and Targets? Position Statement of the Latin American Society of Hypertension[J] . Patricio López-Jaramillo,Antonio Coca,Ramiro Sánchez,Alberto Zanchetti.Hypertension . 2016
[3]  
Is It Time to Reappraise Blood Pressure Thresholds and Targets?: A Statement From the International Society of Hypertension—A Global Perspective[J] . Michael A. Weber,Neil R. Poulter,Aletta E. Schutte,Louise M. Burrell,Masatsugu Horiuchi,Dorairaj Prabhakaran,Agustin J. Ramirez,Ji-Guang Wang,Ernesto L. Schiffrin,Rhian M. Touyz.Hypertension . 2016
[4]  
Impact of Achieved Blood Pressures on Mortality Risk and End-Stage Renal Disease Among a Large, Diverse Hypertension Population[J] . John J. Sim,Jiaxiao Shi,Csaba P. Kovesdy,Kamyar Kalantar-Zadeh,Steven J. Jacobsen.Journal of the American College of Cardiology . 2014 (6)
[5]  
Management of hypertension in adults: the 2013 F rench S ociety of H ypertension guidelines[J] . Jacques Blacher,Jean‐Michel Halimi,Olivier Hanon,Jean‐Jacques Mourad,Atul Pathak,Bruno Schnebert,Xavier Girerd.Fundam Clin Pharmacol . 2014 (1)
[6]  
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis[J] . Lv, Jicheng,Ehteshami, Parya,Sarnak, Mark J,Tighiouart, Hocine,Jun, Min,Ninomiya, Toshiharu,Foote, Celine,Rodgers, Anthony,Zhang, Hong,Wang, Haiyan,Strippoli, Giovanni F M,Perkovic, Vlado.Canadian Medical Association. Journal . 2013 (11)
[7]  
Blood Pressure J-Curve: Current Concepts[J] . Maciej Banach,Wilbert S. Aronow.Current Hypertension Reports . 2012 (6)
[8]  
Relation Between Blood Pressure and Vascular Events and Mortality in Patients With Manifest Vascular Disease: J-Curve Revisited[J] . Johannes A.N. Dorresteijn,Yolanda van der Graaf,Wilko Spiering,Diederick E. Grobbee,Michiel L. Bots,Frank L.J. Visseren.Hypertension . 2012 (1)
[9]  
Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study[J] . Eszter Panna Vamos,Matthew Harris,Christopher Millett,Utz J Pape,Kamlesh Khunti,Vasa Curcin,Mariam Molokhia,Azeem Majeed.BMJ . 2012 (aug3)
[10]   Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET) [J].
Mancia, Giuseppe ;
Schumacher, Helmut ;
Redon, Josep ;
Verdecchia, Paolo ;
Schmieder, Roland ;
Jennings, Garry ;
Yusoff, Khalid ;
Ryden, Lars ;
Liu, G. Lisheng ;
Teo, Koon ;
Sleight, Peter ;
Yusuf, Salim .
CIRCULATION, 2011, 124 (16) :1727-U94